Issue link: http://deals.uberflip.com/i/1531959
Emergency Animal Hospital - Full Service Urgent Care, Emergency Medicine, & Surgery—East Texas, US #67510 Sign NDA ► 2024 Revenue Est. $5,200,000 (9.6% growth) 2024 EBITDA Est. $850,000+ (16.4% of revenue) DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generational Equity of this document. At all times Generational Equity and its affiliate network members is an agent for the seller and not for the buyer. Generational Equity's fees are paid by the seller. Julio Dominguez Managing Director - M&A Email: jdominguez@generational.com Office: 972-232-1118 Generational Equity 3400 N. Central Expressway, Suite 100, Richardson, TX Fax: 972-392-1124 BUSINESS HIGHLIGHTS The Subject Company is a strategically located emergency veterinary facility in the East Texas region with intensive care capabilities, hospitalization, and full 24/7 staffing offering full service urgent care, emergency medicine, and surgery to primarily dog and cat patients in East Texas (80% of 2023 Revenue), North Texas (10%), Gulf Coast Texas (6%), and Louisiana (4%), with no customer concentration. As part of its comprehensive proficiencies, the Company hosts an inhouse laboratory, pharmacy and diagnostics to include digital radiography, ultrasound, lab work and Computed Tomography (CT), and the Company's emergency procedures include blood transfusions, oxygen therapy, antivenin infusions, soft tissue surgery, foreign material removals, wound procedures, and orthopedic surgery. INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 COMPANY STATS > 2 yrs of operations > 30 FT & 4 PT employees > 4,500+ Clientele List > 40% Recurring Accounts > 20,000 sq. ft. facility - 3rd party lease > LLC Corporate Structure > Low CapEx Requirements in the near term INVESTMENT APPEAL • Base Year Performance: The Company's revenue is projected to reach $5,200,000 in 2024. The Company's EBITDA, a key indicator of financial performance, is projected to reach $851,000 in 2024 (16.4% of sales). • Scalable Operating Expenses: The Company has built an effective organization capable of sustaining projected growth. The Company maintains fixed operating expenditures, and future revenue growth will greatly improve profitability. Any increase in revenue will not result in meaningful changes to projected operating expenses. • Superior Name and Reputation: The Company enjoys a long-standing reputation for the quality of its veterinary services and pharmacology products, expertise, dependability, and superior customer support. The Company's reputation in the industry is the result of conducting business with a philosophy that is supported by professionals, principals, values, and ethics. • Demand From Pet Insurance: Demand from pet insurance tracks the performance of companies directly involved in selling insurance policies for cats, dogs and other companion animals. As pet insurance coverage rises, the industry benefits from the increased affordability of services through these policies. Demand from pet insurance is anticipated to surge in the near term, presenting a potential opportunity for the industry. GROWTH OPPORTUNITY > Expanded 24 Hour Care > Increased Sales & Marketing Efforts Historical & Pro Forma Revenue 2023 Geographic Markets